U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C24H20N4O
Molecular Weight 380.4418
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DMH-1

SMILES

CC(C)OC1=CC=C(C=C1)C2=CN3N=CC(=C3N=C2)C4=CC=NC5=C4C=CC=C5

InChI

InChIKey=JMIFGARJSWXZSH-UHFFFAOYSA-N
InChI=1S/C24H20N4O/c1-16(2)29-19-9-7-17(8-10-19)18-13-26-24-22(14-27-28(24)15-18)20-11-12-25-23-6-4-3-5-21(20)23/h3-16H,1-2H3

HIDE SMILES / InChI
Molecular Formula C24H20N4O
Molecular Weight 380.4418
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/24603907 | https://www.ncbi.nlm.nih.gov/pubmed/26683138 | https://www.ncbi.nlm.nih.gov/pubmed/26235139

DMH1 is a potent and selective inhibitor of BMP signaling. DMH1 is a direct inhibitor of ALK2 BMP type-I receptor ALK2 (activin receptor like kinase-2). DMH1 potently inhibits neoplastic phenotype in cancer cells.

Originator

Approval Year

Unknown
139594
Targets

Targets

Primary TargetPharmacologyConditionPotency
Inhibitor
8297
 107.9 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Basic research
Unknown

Approved Use

Unknown
Primary
Basic research
Unknown

Approved Use

Unknown
Primary
Basic research
Unknown

Approved Use

Unknown
Primary
Preclinical
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
DMH1, a novel BMP small molecule inhibitor, increases cardiomyocyte progenitors and promotes cardiac differentiation in mouse embryonic stem cells.
2012
(4-[6-(4-isopropoxyphenyl)pyrazolo [1,5-a]pyrimidin-3-yl] quinoline) is a novel inhibitor of autophagy.
2014 Nov
Inhibition of BMP signaling suppresses metastasis in mammary cancer.
2015 May 7

Sample Use Guides

In Vivo Use Guide
Female mice expressing MMTV.PyVmT were implanted with a 6 week slow-release osmotic pump containing DMH1
Route of Administration: Unknown
In Vitro Use Guide
10-100 uM DMH1 dose-dependently inhibits astrocytic proliferation and migration in vitro
Substance Class Chemical
Created
by admin
on Sat Dec 16 20:01:22 GMT 2023
Edited
by admin
on Sat Dec 16 20:01:22 GMT 2023
Record UNII
BVR5X3H6XM
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DMH-1
Code English
4-[6-[4-(1-Methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline
Systematic Name English
Quinoline, 4-[6-[4-(1-methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-
Systematic Name English
DMH 1
Code English
Code System Code Type Description
PUBCHEM
50997747
Created by admin on Sat Dec 16 20:01:22 GMT 2023 , Edited by admin on Sat Dec 16 20:01:22 GMT 2023
PRIMARY
FDA UNII
BVR5X3H6XM
Created by admin on Sat Dec 16 20:01:22 GMT 2023 , Edited by admin on Sat Dec 16 20:01:22 GMT 2023
PRIMARY
CAS
1206711-16-1
Created by admin on Sat Dec 16 20:01:22 GMT 2023 , Edited by admin on Sat Dec 16 20:01:22 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966